Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Paysign
PAYS
$501M
| $87.1K | ﹤0.01% |
41,104
-11,074
| -21% | -$29.6K |
|
4327
ReNew
RNW
$2.27B
| $87K | ﹤0.01% |
14,773
-17,350
| -54% | -$112K |
|
4328
Nautilus Biotechnolgy
NAUT
$124M
| $86.9K | ﹤0.01% |
100,967
-24,237
| -19% | -$36K |
|
4329
BRC Group Holdings
RILY
$288M
| $86.5K | ﹤0.01% |
22,364
-33,283
| -60% | -$151K |
|
4330
Atossa Therapeutics
ATOS
$20.6M
| $86.5K | ﹤0.01% |
8,572
-4,225
| -33% | -$51.3K |
|
4331
Tango Therapeutics
TNGX
$4.43B
| $86.4K | ﹤0.01% |
63,032
-36,742
| -37% | -$90.2K |
|
4332
Atomera
ATOM
$200M
| $85.7K | ﹤0.01% |
21,436
+11,436
| +114% | +$89K |
|
4333
Twin Disc
TWIN
$329M
| $85.5K | ﹤0.01% |
11,301
-5,491
| -33% | -$53.3K |
|
4334
TScan Therapeutics
TCRX
$48.6M
| $85.4K | ﹤0.01% |
61,850
-5,658
| -8% | -$12.2K |
|
4335
Riskified
RSKD
$694M
| $85.2K | ﹤0.01% |
18,433
-1,486
| -7% | -$7.49K |
|
|
IMA
4336
ImageneBio Inc
IMA
$63M
| $84.7K | ﹤0.01% |
5,515
-10,761
| -66% | -$186K |
|
4337
Veru
VERU
$36M
| $84.4K | ﹤0.01% |
17,225
-3,427
| -17% | -$21.2K |
|
4338
Vanguard Morningstar Growth ETF
VUG
$220B
| $84.2K | ﹤0.01% |
1,362
-56,370
| -98% | -$3.8M |
|
4339
SES AI
SES
$203M
| $83.5K | ﹤0.01% |
160,388
-36,331
| -18% | -$33.4K |
|
4340
Perion Network
PERI
$375M
| $83.3K | ﹤0.01% |
10,232
| – | – |
|
|
TSE
4341
DELISTED
Trinseo
TSE
| $82.9K | ﹤0.01% |
22,537
-25,815
| -53% | -$117K |
|
4342
inTEST
INTT
$155M
| $82.8K | ﹤0.01% |
11,846
-1,627
| -12% | -$13.5K |
|
4343
Lakeland Industries
LAKE
$113M
| $81.1K | ﹤0.01% |
3,991
-6,736
| -63% | -$155K |
|
4344
Consumer Portfolio Services
CPSS
$202M
| $80.5K | ﹤0.01% |
9,289
-3,858
| -29% | -$40.1K |
|
4345
Duluth Holdings
DLTH
$155M
| $79.9K | ﹤0.01% |
45,899
-9,926
| -18% | -$26.8K |
|
4346
Energy Vault
NRGV
$517M
| $79.6K | ﹤0.01% |
114,508
-51,011
| -31% | -$78.4K |
|
4347
Acumen Pharmaceuticals
ABOS
$155M
| $79.5K | ﹤0.01% |
72,265
-20,817
| -22% | -$29.7K |
|
4348
Grupo Aeroportuario del Sureste
ASR
$8.27B
| $79.4K | ﹤0.01% |
290
-2,507
| -90% | -$686K |
|
|
CRON
4349
Cronos Group
CRON
$1.06B
| $79.4K | ﹤0.01% |
43,851
-440
| -1% | -$851 |
|
4350
Douglas Elliman
DOUG
$154M
| $78.6K | ﹤0.01% |
45,686
-43,266
| -49% | -$78.3K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.